Bill > HR5657

This bill, the Medical Marijuana Research Act, aims to facilitate and encourage research on marijuana (also referred to as "marihuana") for medical purposes. Key provisions include: 1. Requiring the Secretary of Health and Human Services to continue producing and supplying marijuana for research through the National Institute on Drug Abuse Drug Supply Program, and to establish a specialized process for manufacturers and distributors to supply marijuana products to qualified researchers. 2. Amending the Controlled Substances Act to create a new registration process for qualified marijuana researchers, allowing them to conduct research on marijuana without the same restrictions as other Schedule I substances. 3. Authorizing the registration of manufacturers and distributors to produce and supply marijuana specifically for use by qualified researchers. 4. Prohibiting the reinstatement of a previous interdisciplinary review process for non-NIH-funded marijuana research. 5. Requiring the Secretary to review and report on the results of marijuana research and consider whether marijuana should be rescheduled under the Controlled Substances Act. The bill also includes provisions related to production quotas, compliance with international treaties, and definitions of key terms like "qualified marijuana researcher."

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/5657/all-info